Quest Diagnostics Incorporated

NYSE (USD): Quest Diagnostics Incorporated (DGX)

Last Price

152.71

Today's Change

-0.71 (0.46%)

Day's Change

152.20 - 153.51

Trading Volume

224,034

Overview

Market Cap

17 Billion

Shares Outstanding

111 Million

Avg Volume

833,846

Avg Price (50 Days)

156.90

Avg Price (200 Days)

146.06

PE Ratio

20.53

EPS

7.44

Earnings Announcement

30-Jan-2025

Previous Close

153.42

Open

152.41

Day's Range

152.2 - 153.51

Year Range

123.04 - 165.32

Trading Volume

224,143

Price Change Highlight

1 Day Change

-0.46%

5 Day Change

0.68%

1 Month Change

-5.89%

3 Month Change

-1.11%

6 Month Change

10.18%

Ytd Change

8.44%

1 Year Change

11.66%

3 Year Change

-9.83%

5 Year Change

43.40%

10 Year Change

125.30%

Max Change

4263.14%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Diagnostics & Research

Description:

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment